The interaction of HA and CD44 was found to promote epidermal growth factor receptor (EGFR)-mediated pathways in different tumor entities, in turn leading to tumor cell proliferation and survival via mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT activation [156]. Here, CD44 is linked to neoplasm.